American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -990 | 196 | -376 | 266 | 1,031 |
| Depreciation Amortization | 437 | 376 | 378 | 269 | 168 |
| Accounts receivable | -53 | 58 | -262 | 94 | -217 |
| Accounts payable and accrued liabilities | 312 | -288 | 23 | 621 | -171 |
| Other Working Capital | -69 | -257 | -597 | -766 | -652 |
| Other Operating Activity | -242 | 257 | 462 | -350 | 525 |
| Operating Cash Flow | $-605 | $342 | $-372 | $134 | $684 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -706 | -803 | -133 | -601 | -272 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 150 |
| Investing Cash Flow | $-706 | $-803 | $-133 | $-601 | $-122 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 547 | 176 | N/A | N/A | N/A |
| Debt Issued | 539 | 775 | 25 | N/A | 25 |
| Debt Repayment | -103 | -627 | -71 | -61 | -181 |
| Common Stock Issued | 23 | 332 | 3 | 581 | 305 |
| Financing Cash Flow | $1,006 | $656 | $-43 | $520 | $149 |
| Beginning Cash Position | 641 | 446 | 995 | 942 | 231 |
| End Cash Position | 336 | 641 | 446 | 995 | 942 |
| Net Cash Flow | $-305 | $195 | $-548 | $53 | $711 |
| Free Cash Flow | |||||
| Operating Cash Flow | -605 | 342 | -372 | 134 | 684 |
| Capital Expenditure | -706 | -803 | -133 | -601 | -272 |
| Free Cash Flow | -1,311 | -461 | -505 | -467 | 412 |